The Pathophysiology of Gestational Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 163 of the 175 references it cites were found in a registry or an index; 42 of the 157 sources its claims cite were checked for support.
Abstract
Review of risk factors and maternal and child consequences of gestational diabetes mellitus.
Overview
CoChat Summary
TL;DR
This review summarizes the proposed pathophysiology of gestational diabetes mellitus (GDM), emphasizing that most cases involve β-cell dysfunction on a background of chronic insulin resistance. It argues that genetic, epigenetic, environmental, placental, inflammatory, oxidative, and microbiome-related factors likely interact, but the molecular mechanisms remain incompletely defined.
Key findings
- GDM affects approximately 14% of pregnancies worldwide according to 2017 IDF estimates, representing about 18 million births annually; the abstract also states approximately 16.5% worldwide.
- The review states that the vast majority (~80%) of GDM cases present as β-cell dysfunction on a background of chronic insulin resistance.
- In GDM, the rate of insulin-stimulated glucose uptake is reduced by 54% compared with normal pregnancy.
- The paper reports several outcome estimates: ~60% of women with prior GDM develop T2DM later in life, the yearly conversion risk is ~2 to 3%, and one study found a 63% increased risk of CVD among women with a history of GDM.
Methods
- This is a narrative review of the pathophysiology of GDM; it does not present a new experimental or clinical study.
- The paper synthesizes previously published evidence on glucose regulation in pregnancy, classification/prevalence, risk factors, consequences, and molecular mechanisms across tissues and systems.
- The analysis is descriptive and integrative, drawing on cited studies, including epidemiological studies, animal studies, mechanistic studies, and large cohort findings such as the HAPO Study (23,000 pregnant women).
Limitations
- The paper explicitly notes that epidemiological studies of risk factors for GDM are limited and typically afflicted by confounding factors, and that inconsistencies in diagnostic criteria and risk-factor measurement make studies hard to compare.
- The review states that molecular mechanisms underlying GDM are poorly defined and that greater understanding is required to develop effective treatments and prevention strategies.
- It is evident from the text that this is not an original empirical study, so it cannot establish causal effects on its own; it relies on secondary synthesis of heterogeneous prior literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
40 Valid · 2 Not valid · 86 Not checked · 24 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This loss of β-cell mass has been linked to epigenetic downregulation of pancreatic homeobox transcription factor (Pdx1), which is essential for normal β-cell differentiation in the embryo [79].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [79] Pinney, 2010, Epigenetic mechanisms in the development of type 2 diabetes, Trends Endocrinol. Metab. sourceExperimental — accuracy not yet measured
The ‘Chromatin Remodeling in the β-cell of IUGR rats’ section reports epigenetic repression of Pdx-1 in growth-restricted rats and describes its critical role in pancreatic development and β-cell differentiation. It does not link that repression to a loss of β-cell mass; it instead discusses β-cell secretory dysfunction, and notes that a milder Pdx-1 reduction in mice permits normal β-cell mass. Page numbers were not available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [75] Prentki, 2006, Islet beta cell failure in type 2 diabetes, J. Clin. Investig. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) proposes that one or a small number of β-cell defects can become weak links when β-cells must compensate for insulin resistance. That supports the general idea of deficiencies becoming consequential under increased demand. The review-series passage mentioning pregnancy (page unavailable) instead discusses maternal hyperglycemia as a risk factor for the offspring; it does not say pregnancy exposes a pre-existing β-cell deficiency in the pregnant person. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, glucotoxicity is also thought to result in β-cell apoptosis over time [76].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Supportedcites [76] Ashcroft, 2017, Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells?, Cell MeTable source
The Abstract states that elevated plasma glucose leads to β-cell dysfunction and death and describes glycogen accumulation as contributing to this ‘glucotoxicity.’ The section ‘An Emerging Role for Glycogen in the Pathophysiology of Diabetes’ reports increased apoptosis in mouse β-cells with substantial glycogen stores. It qualifies the mechanism: apoptosis appears to result from glycogen accumulation rather than elevated glucose alone. Page numbers were not available in our copy. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“While potentially beneficial in times of famine, a mismatch between nutritional status in the womb and nutritional status once born can contribute to the development of obesity and metabolic disease [53,54].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Not checked — no full text of the sourcecites [53] Vickers, 2000, Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition, Am. J. Physiol. Endocrinol. MeTable source
- Supportedcites [54] Desai, 2014, Maternal obesity and high-fat diet program offspring metabolic syndrome, Am. J. Obstet. Gynecol. source
The Methods (The Offspring; page not provided) describe groups with different high-fat-diet exposures during pregnancy and lactation, including both mismatched combinations. The Discussion (page not provided) reports increased offspring adiposity or obesity and metabolic disturbances in these groups. This supports the attributed claim that a prenatal–postnatal nutritional mismatch can contribute to obesity and metabolic disease. (LLM, conf=0.90)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These individuals are more likely to have experienced hyperglycemia and β-cell fatigue even before birth, predisposing them to hyperglycemia during times of later metabolic stress, such as during pregnancy [55].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Partly supportedcites [55] Portha, B., Chavey, A., and Movassat, J. (2011). Early-Life Origins of Type 2 Diabetes: Fetal Programming of the Beta-Cell Mass. Exp. Diabetes Res., 2011. sourceExperimental — accuracy not yet measured
Section 4 (page unavailable) links early-life stressors, including maternal overnutrition, to later endocrine pancreatic deficiency and says pregnancy can expose a latent low insulin response in female offspring. It also describes hyperglycemia during fetal and/or early postnatal life. The copy does not establish that overnourished individuals experienced β-cell fatigue before birth; the discussion relies substantially on animal models and does not isolate prenatal exposure for every case. (LLM, conf=0.84)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
81 more claims · 18 with their cited sources checked
Create a free account to see all 152 claims and to verify the 30 references still open.
- Probably not a substantial claim. 19
- It may state two separate claims as one. 54
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An increased secretion of insulin-antagonistic hormones (placental hormones, cortisol) during pregnancy results in an increased insulin resistance, which, at the end of the third trimester, reaches a value similar to full-blown type 2 diabetes [9,42].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mechanisms of β-cell hypertrophy and proliferation, resulting in a 300% increase in insulin secretion in the first two trimesters of physiological pregnancy, is insufficient to explain GDM [9,39].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Despite numerous studies, the pathogenesis of GDM remains unclear, and the results obtained so far indicate a complex mechanism of interaction of many genetic, metabolic and environmental factors [9].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
In the citing paper
“Under GDM, maternal insulin resistance increases the flux of glucose to the fetal circulation and contributes to increased fetal glucose uptake and growth [8].”
From Evaluating Traditional Chinese Medicine and Herbal Products for the Treatment of Gestational Diabetes Mellitus (2019) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“In most cases, this hyperglycemia is the result of impaired glucose tolerance due to pancreatic β-cell dysfunction on a background of chronic insulin resistance.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 4. Conclusions
“in the majority of cases, pancreatic β-cells fail to compensate for a chronic fuel surfeit, leading to eventual insulin resistance, hyperglycemia, and an increased supply of glucose to the growing fetus.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“GDM affects approximately 16.5% of pregnancies worldwide, and this number is set to increase with the escalating obesity epidemic.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction
“According to the most recent (2017) International Diabetes Federation (IDF) estimates, GDM affects approximately 14% of pregnancies worldwide, representing approximately 18 million births annually [2].”
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 1×
“Both red meat and animal protein decrease levels of Firmicutes, while high dietary fiber increase them [133].”
BackgroundChanges of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277 · cited 1×
“Increased gut permeability is thought to facilitate the movement of inflammatory mediators from the gut into the circulation, promoting systemic insulin resistance [134,136].”
BackgroundYamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 1×
“Adiponectin enhances insulin signaling and fatty acid oxidation, and it inhibits gluconeogenesis [104].”
Backgroundβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“Non-diabetic obese individuals exhibit adequate adipose tissue expansion in response to fuel surfeit, and therefore maintain healthy blood glucose concentrations, sufficient β-cell compensation, and avoid chronic insulin resistance [110,111].”
Background
Research works printed but not linked: 1
- Halliwell, B., and Gutteridge, J. (2007). Free Radicals in Biology and Medicine, Oxford University Press. [4th ed.].
Cited by
An Update on the Epidemiology of Type 2 Diabetes
Tinajero, M. G., & Malik, V. S. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.05.013 · Cited by 471
Gestational Diabetes Mellitus: A Harbinger of the Vicious Cycle of Diabetes
Alejandro, E. U., Mamerto, T. P., Chung, G., Villavieja, A., Gaus, N. L., Morgan, E., & Pineda-Cortel, M. R. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145003 · Cited by 353
“GDM is characterized by impaired glucose tolerance as a result of maternal pancreatic β-cell dysfunction, resulting in the insufficiency of insulin to regulate glucose homeostasis during pregnancy [10].”
BackgroundOrnoy, A., Becker, M., Weinstein-Fudim, L., & Ergaz, Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062965 · Cited by 339
Diabetes mellitus: an overview of the types, symptoms, complications and management
Cloete, L. (2022) · Nursing Standard · doi:10.7748/ns.2021.e11709 · Cited by 332
IL-6 and IL-8: An Overview of Their Roles in Healthy and Pathological Pregnancies
Vilotić, A., Nacka-Aleksić, M., Pirković, A., Bojić-Trbojević, Ž., Dekanski, D., & Jovanović Krivokuća, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314574 · Cited by 236
“As in type 2 DM, insulin resistance (IR) and β-cell dysfunction play a central role in the pathophysiology of GDM [249].”
BackgroundNutrigenetics, epigenetics and gestational diabetes: consequences in mother and child
Franzago, M., Fraticelli, F., Stuppia, L., & Vitacolonna, E. (2019) · Epigenetics · doi:10.1080/15592294.2019.1582277 · Cited by 234
“One of the possible causes of this increased prevalence could be ascribed to the advanced age of pregnancy, which in turn is related to the presence in pregnant women of risk factors, such as obesity and overweight, making them more susceptible to hyperglycemia during pregnancy [21,28].”
BackgroundHasain, Z., Mokhtar, N. M., Kamaruddin, N. A., Mohamed Ismail, N. A., Razalli, N. H., Gnanou, J. V., & Raja Ali, R. A. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00188 · Cited by 225
“However, susceptible pregnant women are unable to compensate for insulin resistance and will develop hyperglycemia due to insufficient insulin secretion secondary to pancreatic β-cell dysfunction (Kim, 2014; Plows et al., 2018).”
BackgroundGestational Diabetes Mellitus—Recent Literature Review
Modzelewski, R., Stefanowicz-Rutkowska, M. M., Matuszewski, W., & Bandurska-Stankiewicz, E. M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195736 · Cited by 223
“An increased secretion of insulin-antagonistic hormones (placental hormones, cortisol) during pregnancy results in an increased insulin resistance, which, at the end of the third trimester, reaches a value similar to full-blown type 2 diabetes [9,42].”
BackgroundMcElwain, C. J., Tuboly, E., McCarthy, F. P., & McCarthy, C. M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00655 · Cited by 208
“As the fetus develops, a surge of hormone secretion, such as placental lactogen and estrogen, promote a state of insulin resistance, which facilitates a rise in blood glucose levels to fuel fetal growth (9).”
BackgroundHussain, T., Tan, B., Murtaza, G., Liu, G., Rahu, N., Saleem Kalhoro, M., Hussain Kalhoro, D., Adebowale, T. O., Usman Mazhar, M., Rehman, Z. U., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104629 · Cited by 194
Fetal–Maternal Exposure to Endocrine Disruptors: Correlation with Diet Intake and Pregnancy Outcomes
Rolfo, A., Nuzzo, A. M., De Amicis, R., Moretti, L., Bertoli, S., & Leone, A. (2020) · Nutrients · doi:10.3390/nu12061744 · Cited by 189
“Gestational diabetes (GDM) occurs when pregnant women have dysfunctional β-cells, unable to balance the increased requirements of insulin [110].”
BackgroundRole of Oxidative Stress and Inflammation in Gestational Diabetes Mellitus
Saucedo, R., Ortega-Camarillo, C., Ferreira-Hermosillo, A., Díaz-Velázquez, M. F., Meixueiro-Calderón, C., & Valencia-Ortega, J. (2023) · Antioxidants · doi:10.3390/antiox12101812 · Cited by 179
Estienne, A., Bongrani, A., Reverchon, M., Ramé, C., Ducluzeau, P.-H., Froment, P., & Dupont, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184431 · Cited by 173
“IR also promotes endogenous hepatic glucose production and lipolysis in adipose tissue, resulting in a further increase in blood glucose and free fatty acid concentrations [225].”
BackgroundGestational diabetes is driven by microbiota-induced inflammation months before diagnosis
Pinto, Y., Frishman, S., Turjeman, S., Eshel, A., Nuriel-Ohayon, M., Shtossel, O., Ziv, O., Walters, W., Parsonnet, J., Ley, C., et al. (2023) · Gut · doi:10.1136/gutjnl-2022-328406 · Cited by 163
Szczuko, M., Kikut, J., Komorniak, N., Bilicki, J., Celewicz, Z., & Ziętek, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249628 · Cited by 172
“, excessive body weight, age of the mother and her diet [57].”
BackgroundLewandowska, M., Więckowska, B., & Sajdak, S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061980 · Cited by 153
“Inflammation, oxidative stress, and endothelial dysfunction are important elements of pregnancy hypertension and diabetes [8,10].”
InfluentialRentzeperi, E., Pegiou, S., Koufakis, T., Grammatiki, M., & Kotsa, K. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12030454 · Cited by 140
“However, in an individual with pre-existing β-cell dysfunction this process of adaptation is not possible and therefore a hyperglycemic state occurs [19].”
BackgroundZhang, H., Wang, Q., He, S., Wu, K., Ren, M., Dong, H., Di, J., Yu, Z., & Huang, C. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.137349 · Cited by 143
Vitamin B6 and Diabetes: Relationship and Molecular Mechanisms
Mascolo, E., & Vernì, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103669 · Cited by 156
“It is associated with insulin resistance, in turn generated by a combined action of pregnancy hormones and other factors [25].”
BackgroundYu, G., Jin, M., Huang, Y., Aimuzi, R., Zheng, T., Nian, M., Tian, Y., Wang, W., Luo, Z., Shen, L., et al. (2021) · Environment International · doi:10.1016/j.envint.2021.106621 · Cited by 141
Pathophysiology of Gestational Diabetes Mellitus
Berberoglu, Z. (2019) · EMJ Diabetes · doi:10.33590/emjdiabet/10313616 · Cited by 129
Overweight and obesity in pregnancy: their impact on epigenetics
Reichetzeder, C. (2021) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-00905-6 · Cited by 164
Metabolomic Biomarkers in Gestational Diabetes Mellitus: A Review of the Evidence
Alesi, S., Ghelani, D. P., Rassie, K. L., & Mousa, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115512 · Cited by 152
“If endocrine pancreatic function is insufficient, hyperglycaemia develops, resulting in the clinical picture of GDM (Figure 1) [17].”
BackgroundInfluentialPregnancy complications and later life women's health
McNestry, C., Killeen, S. L., Crowley, R. K., & McAuliffe, F. M. (2023) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14523 · Cited by 183
Gestational Diabetes Mellitus and Maternal Immune Dysregulation: What We Know So Far
McElwain, C. J., McCarthy, F. P., & McCarthy, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084261 · Cited by 142
“The pathophysiology of GDM is not fully understood, with a predominant hypothesis linking aberrant hormone expression from the placenta to maternal metabolic dysfunction and diminished insulin functionality [9].”
BackgroundPersistence of Risk for Type 2 Diabetes After Gestational Diabetes Mellitus
Diaz-Santana, M. V., O’Brien, K. M., Park, Y.-M. M., Sandler, D. P., & Weinberg, C. R. (2022) · Diabetes Care · doi:10.2337/dc21-1430 · Cited by 124
Barbe, A., Bongrani, A., Mellouk, N., Estienne, A., Kurowska, P., Grandhaye, J., Elfassy, Y., Levy, R., Rak, A., Froment, P., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071526 · Cited by 120
“According to last International Diabetes Federation estimation, it affects approximately 14% of pregnancies worldwide, representing ←18 million births annually [193].”
BackgroundInfluentialStern, C., Schwarz, S., Moser, G., Cvitic, S., Jantscher-Krenn, E., Gauster, M., & Hiden, U. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312722 · Cited by 114
“Animal studies have shown that during healthy pregnancy, insulin resistance results in pancreatic β-cell hyperplasia, hypertrophy and increased glucose-stimulated insulin secretion [6], counteracting an excessive glucose shift to the fetus.”
BackgroundInfluentialYe, Y., Xiong, Y., Zhou, Q., Wu, J., Li, X., & Xiao, X. (2020) · Journal of Diabetes Research · doi:10.1155/2020/4168340 · Cited by 132
“Furthermore, our findings underscore the roles of glucose and lipid metabolism in the development of GDM [4, 30].”
BackgroundNon-Coding RNA: Role in Gestational Diabetes Pathophysiology and Complications
Filardi, T., Catanzaro, G., Mardente, S., Zicari, A., Santangelo, C., Lenzi, A., Morano, S., & Ferretti, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114020 · Cited by 120
“Thus, the insulin resistance state observed in physiological pregnancy is an adaptive response that favors the rise in glucose and free fatty acid blood levels, shifting energy sources from the mother to the foetus [19,20].”
BackgroundUnveiling Gestational Diabetes: An Overview of Pathophysiology and Management
Mittal, R., Prasad, K., Lemos, J. R. N., Arevalo, G., & Hirani, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052320 · Cited by 183
“In the subgroup of the 5–10% of women who develop T1D post-pregnancy, the dys-glycemia is frequently linked to the presence of autoantibodies [63].”
InfluentialKrawczyk, M., Burzyńska-Pędziwiatr, I., Woźniak, L. A., & Bukowiecka‐Matusiak, M. (2023) · Biomolecules · doi:10.3390/biom13091402 · Cited by 137
“Gestational diabetes leads to numerous severe complications in both mothers and their children [11].”
Backgroundde Mendonça, E. L. S. S., Fragoso, M. B. T., de Oliveira, J. M., Xavier, J. A., Goulart, M. O. F., & de Oliveira, A. C. M. (2022) · Antioxidants · doi:10.3390/antiox11010129 · Cited by 126
“Among these members, STAT3 has stood out, mainly for its involvement with insulin resistance and related pathologies, including GDM [2,3,84,97].”
BackgroundInfluentialEnvironmental pollution and the risk of developing metabolic disorders: obesity and diabetes
Khalil, W. J., Akeblersane, M., Khan, A. S., Moin, A. S. M., & Butler, A. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108870 · Cited by 95
COVID-19 pandemic: Impact on gestational diabetes mellitus prevalence
Zanardo, V., Tortora, D., Sandri, A., Severino, L., Mesirca, P., & Straface, G. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109149 · Cited by 93
“[7] Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH.”
BackgroundInfluentialKynurenine Pathway in Diabetes Mellitus—Novel Pharmacological Target?
Kozieł, K., & Urbańska, E. M. (2023) · Cells · doi:10.3390/cells12030460 · Cited by 111
“In the long term, children born to women with GDM are at higher risk of obesity, DMT2, cardiovascular disease, and other metabolic diseases [95,96].”
BackgroundZhang, H., Dong, H., Ren, M., Liang, Q., Shen, X., Wang, Q., Yu, L., Lin, H., Luo, Q., Chen, W., et al. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.134390 · Cited by 94
Ye, G., Zhang, L., Wang, M., Chen, Y., Gu, S., Wang, K., Leng, J., Gu, Y., & Xie, X. (2019) · Journal of Diabetes Research · doi:10.1155/2019/6081248 · Cited by 103
“However, the normal insulin levels during pregnancy do not adequately occur in all pregnancies, except in those with preexisting insulin resistance or women who cannot increase insulin secretion, resulting in GDM [2, 3].”
Choudhury, A. A., & Rajeswari, V. D. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121069 · Cited by 103
Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases
Guerra, J. V. D. S., Dias, M. M. G., Brilhante, A. J. V. C., Terra, M. F., García‐Arévalo, M., & Figueira, A. C. M. (2021) · Nutrients · doi:10.3390/nu13082830 · Cited by 111
Xu, Y., Zhang, M., Zhang, J., Sun, Z., Ran, L., Ban, Y., Wang, B., Hou, X., Zhai, S., Ren, L., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00266.2019 · Cited by 95
The Role of Dietary Carbohydrates in Gestational Diabetes
Mustad, V. A., Huynh, D. T. T., López-Pedrosa, J. M., Campoy, C., & Rueda, R. (2020) · Nutrients · doi:10.3390/nu12020385 · Cited by 101
“To adjust to this physiological change, pancreatic β cells suffer hyperplasia and hypertrophy to increase insulin secretion, maintaining maternal euglycemic state and preserving the embryo [19].”
BackgroundMitochondrial dysfunction in placental trophoblast cells experiencing gestational diabetes mellitus
Fisher, J. J., Vanderpeet, C. L., Bartho, L. A., McKeating, D. R., Cuffe, J. S. M., Holland, O. J., & Perkins, A. V. (2020) · The Journal of Physiology · doi:10.1113/jp280593 · Cited by 96
“Along with lifelong impacts on fetal/child health such as increased risk of cardiovascular disease, GDM increases the risk of maternal pregnancy complications like preeclampsia (Plows et al. 2018), as well as maternal risk of type 2 diabetes, all of which have a significant impact and burden of disease (extensively re…”
BackgroundUnravelling innervation of pancreatic islets
Hampton, R. F., Jiménez-González, M., & Stanley, S. A. (2022) · Diabetologia · doi:10.1007/s00125-022-05691-9 · Cited by 89
“Women with gestational diabetes show increased sympathetic activity, impaired glucose tolerance, insulin resistance, and chronic hyperglycaemia [164, 165] Sympathetic innervation may also modulate immune activity in diabetes.”
BackgroundMitochondrial Dysfunction in Obesity and Reproduction
Das, M., Sauceda, C., & Webster, N. J. G. (2020) · Endocrinology · doi:10.1210/endocr/bqaa158 · Cited by 89
Muche, A. A., Olayemi, O. O., & Gete, Y. K. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2492-3 · Cited by 106
The exosome: a review of current therapeutic roles and capabilities in human reproduction
Dimik, M., Abeysinghe, P., Logan, J., & Mitchell, M. D. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01225-3 · Cited by 96
“The development of GDM is linked to the impairment of glucose tolerance in relation to pancreatic β-cell dysfunction and is usually more common in women with pre-existing risk factors [85].”
BackgroundMaternal gut microbiota in the health of mothers and offspring: from the perspective of immunology
Lu, X., Shi, Z., Jiang, L., & Zhang, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1362784 · Cited by 114
Immunoendocrine Dysregulation during Gestational Diabetes Mellitus: The Central Role of the Placenta
Olmos‐Ortiz, A., Flores‐Espinosa, P., Díaz, L., Velázquez, P., Ramírez-Isarraraz, C., & Zaga‐Clavellina, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158087 · Cited by 98
“Although adipokines have been described as secretion products of adipose tissue, the placenta can synthesize adipokines such as chemerin, omentin‐1, visfatin, leptin, and adiponectin‐like adipose tissue [8,135].”
BackgroundGestational Diabetes Mellitus Screening and Diagnosis
Sert, Ü. Y., & Ozgu-Erdinc, A. S. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_512 · Cited by 94
Pathirana, M. M., Lassi, Z. S., Alì, A., Arstall, M. A., Roberts, C. T., & Andraweera, P. H. (2020) · Endocrine · doi:10.1007/s12020-020-02492-1 · Cited by 83
Placental mitochondrial dysfunction with metabolic diseases: Therapeutic approaches
Hebert, J. F., & Myatt, L. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165967 · Cited by 81
Lin, J., Jin, H., & Chen, L. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-04006-x · Cited by 86
“However, alternative standards are still used in some centers and countries including Australia [37].”
BackgroundInfluentialA pathway level analysis of PFAS exposure and risk of gestational diabetes mellitus
Birru, R. L., Liang, H.-W., Farooq, F., Bedi, M., Feghali, M., Haggerty, C. L., Mendez, D. D., Catov, J. M., Ng, C. A., & Adibi, J. J. (2021) · Environmental Health · doi:10.1186/s12940-021-00740-z · Cited by 70
“through the placenta to the fetus to fuel growth [9].”
BackgroundInfluentialLewandowska, M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18136936 · Cited by 92
“, average 18 million women) depending on the region and diagnostic criteria [4,6,7], and 80–90% of cases develop GDM-1 (when diet treatment was sufficient to normalize glycemia) [3].”
BackgroundBMI and lipidomic biomarkers with risk of gestational diabetes in pregnant women
Wang, Y., Wu, P., Huang, Y., Ye, Y., Yang, X., Sun, F., Ye, Y., Lai, Y., Ouyang, J., Wu, L., et al. (2022) · Obesity · doi:10.1002/oby.23517 · Cited by 68
“Obesity is reported to affect GDM through several possible mechanisms such as impaired β-cell function, insulin resistance, and chronic low-grade inflammation [4, 5].”
BackgroundWhat is known and what remains unresolved regarding gestational diabetes mellitus (GDM)
Vince, K., Perković, P., & Matijević, R. (2020) · Journal of Perinatal Medicine · doi:10.1515/jpm-2020-0254 · Cited by 74
“This is due to a complex combination of genetic, epigenetic and environmental factors as well as a variety of causes which surpass the scope of this review but include development of β-cell dysfunction, chronic insulin resistance, neurohormonal dysfunction (mainly adiponkines), changes in gut microbiome and developmen…”
BackgroundYin, Y., Pan, Y., He, J., Zhong, H., Wu, Y., Ji, C., Liu, L., & Cui, X. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105987 · Cited by 73
Cardiac changes in infants of diabetic mothers
Al‐Beltagi, M., Razaky, O. E., & Amrousy, D. M. E. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i8.1233 · Cited by 85
Epigenetic Changes in Gestational Diabetes Mellitus
Dłuski, D. F., Wolińska, E., & Skrzypczak, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147649 · Cited by 79
“This insulinresistance state in physiological gestation is an adaptive response, which favors the boost in free fatty acid and glucose blood levels, and it shifts the energy source from the mother to the fetus [24,25].”
BackgroundUpdates in Gestational Diabetes Prevalence, Treatment, and Health Policy
Dickens, L. T., & Thomas, C. C. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1147-0 · Cited by 83
Programming of cardiometabolic health: the role of maternal and fetal hyperinsulinaemia
Hufnagel, A., Dearden, L., Fernandez‐Twinn, D. S., & Ozanne, S. E. (2022) · Journal of Endocrinology · doi:10.1530/joe-21-0332 · Cited by 86
“It is now established that compensatory hypertrophy and hyperplasia of the pancreatic ß-cells in the mother is a normal and physiological pregnancy adaptation required to maintain glucose homeostasis which fails in pregnancies with GDM (Plows et al. 2018).”
BackgroundMu, J., Guo, X., Zhou, Y., & Cao, G. (2023) · Nutrients · doi:10.3390/nu15061375 · Cited by 80
“During gestational diabetes, β-cells fail to secrete insulin for the demands of pregnancy, and, when combined with reduced insulin sensitivity, this results in hyperglycemia [38].”
BackgroundAnsari, M. A., Chauhan, W., Shoaib, S., Alyahya, S. A., Ali, M., Ashraf, H., Alomary, M. N., & Al-Suhaimi, E. A. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01369-3 · Cited by 73
“It is a common medical issue that can develop during pregnancy and is associated with an increase in negative outcomes [5].”
BackgroundSun, M., Luo, M., Wang, T., Wei, J., Zhang, S., Shu, J., Zhong, T., Liu, Y., Chen, Q., Zhu, P., et al. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2023-003324 · Cited by 94
Gut Microbiome Changes in Gestational Diabetes
Ionescu, R. F., Enache, R. M., Creţoiu, S. M., & Gașpar, B. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112839 · Cited by 73
“mal or it can be a risk of T2D and of GDM in future pregnancy [17].”
BackgroundBedell, S. (2021) · Current Vascular Pharmacology · doi:10.2174/18756212mta3qndapy · Cited by 57
Wu, S., Jin, J., Hu, K.-L., Wu, Y., & Zhang, D. (2022) · Nutrients · doi:10.3390/nu14122383 · Cited by 72
“Besides, overweight and obesity are intrinsically linked with longterm excessive calorie intake [41], which might be uneasy to change, resulting in a barrier to diet intervention.”
BackgroundExosomes-Associated DNA—New Marker in Pregnancy Complications?
Konečná, B., Tóthová, Ľ., & Repiská, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122890 · Cited by 61
“Chronic insulin resistance leads to β cells dysfunction, leading to glucotoxicity and later to macrosomia and lasting type II diabetes after delivery [41,42].”
BackgroundPathirana, M. M., Lassi, Z. S., Alì, A., Arstall, M. A., Roberts, C. T., & Andraweera, P. H. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09587-0 · Cited by 65
Cellular and Molecular Pathophysiology of Gestational Diabetes
Torres‐Torres, J., Monroy-Muñoz, I. E., Duran, J. P., Solis‐Paredes, J. M., Camacho‐Martinez, Z. A., Baca, D., y Sosa, S. E., Martinez-Portilla, R. J., Rojas‐Zepeda, L., Borboa-Olivares, H. J., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111641 · Cited by 89
Chen, L., Soh, S. E., Tint, M., Loy, S. L., Yap, F. K. P., Tan, K. H., Lee, Y. S., Shek, L. P., Godfrey, K. M., Gluckman, P. D., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-82789-x · Cited by 69
Reproductive risk factors across the female lifecourse and later metabolic health
Nichols, A. R., Chavarro, J. E., & Oken, E. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.01.002 · Cited by 76
Obuchowska, A., Gorczyca, K., Standyło, A., Obuchowska, K., Kimber-Trojnar, Ż., Wierzchowska-Opoka, M., & Leszczyńska‐Gorzelak, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158253 · Cited by 63
“IR is seen in GDM patients, as well as in impaired insulin secretion due to a defect in pancreatic-cell function [33,37,56].”
BackgroundGDM-complicated pregnancies: focus on adipokines
Mallardo, M., Ferraro, S., Daniele, A., & Nigro, E. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06785-0 · Cited by 64
Yao, X., Geng, S., Zhu, L., Jiang, H., & Wen, J. (2023) · Chemosphere · doi:10.1016/j.chemosphere.2023.138866 · Cited by 62
Koos, B. J., & GORNBEIN, J. A. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.07.050 · Cited by 60
Ellerbrock, J., Spaanderman, B., van Drongelen, J., Mulder, E., van Balen, V. A. L., Schiffer, V. M. M. M., Jorissen, L. M., Alers, R., Leenen, J., Ghossein‐Doha, C., et al. (2022) · Nutrients · doi:10.3390/nu14122444 · Cited by 75
“As maternal glucose transport to the fetus is concentration-dependent and insulin-independent, increased plasma levels raise fetal glucose availability, leading to increased fetal growth and metabolic needs [2].”
BackgroundPhysiological and pathological functions of sphingolipids in pregnancy
Fakhr, Y., Brindley, D. N., & Hemmings, D. G. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110041 · Cited by 59
Song, S., Zhang, Y., Qiao, X., Duo, Y., Xu, J., Peng, Z., Zhang, J., Chen, Y., Nie, X., Sun, Q., et al. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13905 · Cited by 69
Cubillos, G., Mönckeberg, M., Plaza, A., Morgan, M., Estévez, P. A., Choolani, M. A., Kemp, M. W., Illanes, S. E., & Perez, C. A. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-05766-4 · Cited by 63
““hidden_layer_sizes” Multi-Layer Perceptron [8, 256], hidden layers: [1, 10]”
BackgroundMolecular Biomarkers for Gestational Diabetes Mellitus and Postpartum Diabetes
Lu, W., & Hu, C. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002160 · Cited by 52
“Similar to diabetes, GDM development has multiple mechanisms, including b-cell dysfunction, insulin resistance, adipose tissue dysfunction, gluconeogenesis, gut microbiota dysbiosis, and oxidative stress.([8]) Owing to this complexity, our current understanding of the pathogenesis of this disease remains limited.”
BackgroundFirst Trimester Microelements and Their Relationships with Pregnancy Outcomes and Complications
Lewandowska, M., Więckowska, B., Sajdak, S., & Lubiński, J. (2020) · Nutrients · doi:10.3390/nu12041108 · Cited by 56
m6A mRNA methylation regulates the development of gestational diabetes mellitus in Han Chinese women
Wang, J., Wang, K., Liu, W., Cai, Y., & Jin, H. (2021) · Genomics · doi:10.1016/j.ygeno.2021.02.016 · Cited by 55
Delanerolle, G., Phiri, P., Zeng, Y., Marston, K., Tempest, N., Busuulwa, P., Shetty, A., Goodison, W., Muniraman, H., Duffy, G., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101016 · Cited by 61
“Risk factors associated with GDM include family history of diabetes, smoking, ethnicity [1] advancing maternal age and polycystic ovarian syndrome [3] (Fig.”
BackgroundJamilian, M., Tabassi, Z., Reiner, Ž., Panahandeh, I., Naderi, F., Aghadavod, E., Amirani, E., Taghizadeh, M., Shafabakhsh, R., Sattari, M., et al. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114519003416 · Cited by 53
“range of unfavourable long-term outcomes for mother and child are attributed to this condition(2).”
BackgroundLin, Q., Zhang, S., Liang, Y., Wang, C., Wang, C., Wu, X., Luo, C., Ruan, Z., Acharya, B. K., Lin, H., et al. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109990 · Cited by 50
Metabolomic and genetic associations with insulin resistance in pregnancy
Liu, Y., Kuang, A., Talbot, O., Bain, J. R., Muehlbauer, M. J., Hayes, M. G., Ilkayeva, O., Lowe, L. P., Metzger, B. E., Newgard, C. B., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05198-1 · Cited by 55
Feng, Y., Qu, X., Chen, Y., Feng, Q., Zhang, Y., Hu, J., & Li, X. (2020) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-020-00618-8 · Cited by 50
Zhang, H., Wang, Q., Benmarhnia, T., Jalaludin, B. B., Shen, X., Yu, Z., Ren, M., Liang, Q., Wang, J., Ma, W., et al. (2021) · Environment International · doi:10.1016/j.envint.2021.106457 · Cited by 56
Novel Biomolecules in the Pathogenesis of Gestational Diabetes Mellitus
Ruszała, M., Niebrzydowska-Tatus, M., Pilszyk, A., Kimber-Trojnar, Ż., Trojnar, M. P., & Leszczyńska‐Gorzelak, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111578 · Cited by 54
“Insulin resistance during pregnancy develops gradually, and finally, in consequence, it leads to hyperglycaemia [9,10].”
BackgroundMaternal Arsenic Exposure and Gestational Diabetes: A Systematic Review and Meta-Analysis
Salmeri, N., Villanacci, R., Ottolina, J., Bartiromo, L., Cavoretto, P. I., Dolci, C., Lembo, R., Schimberni, M., Valsecchi, L., Viganò, P., et al. (2020) · Nutrients · doi:10.3390/nu12103094 · Cited by 47
“Gestational diabetes mellitus is a common complication of pregnancy characterized by a dysfunction of pancreatic β-cells on a background of chronic insulin resistance [47].”
BackgroundMild Gestational Diabetes and Adverse Pregnancy Outcome: A Systemic Review and Meta-Analysis
Yarandi, R. B., Vaismoradi, M., Panahi, M. H., Kymre, I. G., & Behboudi‐Gandevani, S. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.699412 · Cited by 57
“It occurs because of metabolic maladaptation to insulin resistance, and mainly due to the hormonal changes of pregnancy (2).”
BackgroundThe Role of Extracellular Vesicles in β-Cell Function and Viability: A Scoping Review
Chidester, S., Livinski, A. A., Fish, A. F., & Joseph, P. V. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00375 · Cited by 48
“A common feature of T1DM, T2DM, and GDM pathogenesis is impairment of insulin secretion capacity (5, 6).”
BackgroundWang, H., Zhou, W., She, G., Yu, B., & Sun, L. (2020) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-020-00612-0 · Cited by 46
Zhang, Z., Zhou, Z., & Li, H. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14119 · Cited by 50
“There are several risk factors linked to the onset of GDM, such as a higher body mass index (BMI), increased maternal age, family history of GDM, and ethnicity 27,28 .”
BackgroundMonod, C., Kotzaeridi, G., Linder, T., Eppel, D., Rosicky, I., Filippi, V., Tura, A., Hösli, I., & Göbl, C. S. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-02011-w · Cited by 63
“The pathophysiology of GDM appears to be largely similar to that of T2DM, as it develops as a result of both impaired insulin sensitivity and β-cell dysfunction, caused by the metabolic stress of pregnancy [2].”
BackgroundPrevalence of gestational diabetes mellitus and its determinants among pregnant women in Beijing
Wang, C., Jin, L., Tong, M., Zhang, J., Yu, J., & Meng, W. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1754395 · Cited by 45
“A possible reason for this is that overweight and obesity are inherently associated with prolonged, excessive caloric intake, which overwhelms the insulin production of the b-cell and the insulin signaling pathways [28].”
BackgroundXu, Y. X. Z., Xi, S., & Qian, X. (2019) · Journal of Diabetes Research · doi:10.1155/2019/9182595 · Cited by 42
“Under GDM, maternal insulin resistance increases the flux of glucose to the fetal circulation and contributes to increased fetal glucose uptake and growth [8].”
BackgroundAndersson-Hall, U. K., Joelsson, L., Svedin, P., Mallard, C. E., & Holmäng, A. B. (2021) · Clinical Endocrinology · doi:10.1111/cen.14433 · Cited by 46
Metadata
- Authors
- Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H.
- Affiliations
- University of Southern California (US)
- University of Auckland (NZ)
- University of Leicester (GB)
- Corresponding author
- Vickers, Mark H
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-10-26
- Volume
- 19
- Issue
- 11
- Pages
- 3342
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6274679
- OpenAlex
- W2898266729
- Cited by
- 1,874
- References
- 175
- Citations by year
- 2026: 277 · 2025: 298 · 2024: 319 · 2023: 307 · 2022: 295 · 2021: 221 · 2020: 122 · 2019: 33
- FWCI
- 15.21
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- gestational diabetes mellitus, pathophysiology, hyperglycemia in pregnancy, impaired glucose tolerance, beta-cell dysfunction, insulin resistance, maternal obesity, type 2 diabetes risk, macrosomia, cardiovascular risk, GDM prevention, insulin therapy, lifestyle intervention
- MeSH terms
- Adipose Tissue, Animals, Female, Glucose, Humans, Insulin Resistance, Pregnancy, Risk Factors, Diabetes, Gestational, Oxidative Stress, Leptin, Insulin-Secreting Cells, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.